Correlation Between Inhibikase Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on Inhibikase Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Tempest Therapeutics.
Diversification Opportunities for Inhibikase Therapeutics and Tempest Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibikase and Tempest is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Tempest Therapeutics
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.27 times more return on investment than Tempest Therapeutics. However, Inhibikase Therapeutics is 1.27 times more volatile than Tempest Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 138.00 in Inhibikase Therapeutics on August 28, 2024 and sell it today you would earn a total of 96.00 from holding Inhibikase Therapeutics or generate 69.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Tempest Therapeutics |
Inhibikase Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite Inhibikase Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals | Tempest Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance |